Investing In Global health

Advancing funding and commitments to eliminate diseases of poverty!

Each day diseases such as HIV, malaria, TB, as well as many other neglected tropical diseases, cause misery and suffering to millions of people worldwide. These awful diseases rob the futures of millions of young people. They have disastrous consequences on families, communities and nations. They are responsible for holding back huge numbers of people across the world from fulfilling their potential.

DSW recognises the urgent need for improvements to global health. The world has committed to ending HIV & AIDS, malaria and tuberculosis by 2030, and if we are to achieve this, we need to make sure that global health is at the core of the international development agenda.

With the limited progress on achieving international health targets, and the increasing threat of new and deadly infectious disease outbreaks, we are also working hard with partners to secure increased political and financial investment in research and development for global health innovation.

0m +
number of people newly infected with HIV in 2015
0k
malaria-related deaths of children under 5 in 2015
0%
proportion of global TB deaths from low- and middle-income countries
$0bn
the extra funding needed for global health research to hit global health targets

Achieving a breakthrough in Global Health – 3 ways we can harness global health innovation

We have made tremendous and transformative strides in global health in the last 50 years. Diseases like smallpox and polio, diseases once responsible for untold suffering and millions of death, have either been eradicated or are close to extinction. Even in the last thirty years, the global community have achieved significant progress in fighting the deadliest infectious diseases; for example, according to the World Health Organisation, the number of people dying from HIV-related causes declined by 24% in 2000–2014 and by over 40% since 2004, the peak year for HIV-related deaths. These achievements have been made on the back of concerted and coordinated global cooperation, and constant innovation in the research, development and roll-out of live-saving medicines.
But much remains to be done. If we are to secure and build upon the stunning achievements of recent years, achieving the targets of the 2030 Agenda for Sustainable Development, we need to invest now and accelerate global health innovation.

  • Connector.

    Make innovation a priority

    Innovation has the potential to deliver new vaccines, more effective and accessible treatments for diseases like TB, and interventions to reduce maternal mortality. Recognising the value of innovation in European and international agendas is crucial to unlocking its potential.

  • Connector.

    Targeted and smart investment

    Funding for R&D for diseases of poverty has stagnated since 2008, and it is estimated that we would need to double global annual investment in R&D to $6bn if we are serious about ending preventable diseases. Not only do we need to increase spending on global health, but we need to make sure that administrative and bureaucratic obstacles are reduced so that funding goes where it is needed.

  • Connector.

    Encourage partnerships

    We need innovation not only for new medicines, but also in how we develop them. Models like Product Development Partnerships – bringing together public and private, industry and academia – have been successful in developing a new generation of life-saving interventions.

Let’s Save Lives

In spring 2015, DSW worked with Politicians from across Europe to bring this message to the highest levels of decision making in the EU. We continue to bring this message with us in all out conversations with politicians and the people that hold the purse strings.

An introduction to Let’s Save Lives from Renate Baehr

Video-message of Commissioner Moedas for the Tuberculosis Day

Sign up for alerts about our work to improve access to life-saving medicines